Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
ACS Omega ; 9(11): 13323-13331, 2024 Mar 19.
Artículo en Inglés | MEDLINE | ID: mdl-38524429

RESUMEN

Inhibitory foam technology plays an important role in inhibiting coal spontaneous combustion. To enhance the stability and inhibitory performance of inhibitory foam for coal spontaneous combustion, a novel physicochemical composite inhibitor was developed in this work. CaCl2 was chosen as an inorganic salt physical inhibitor to compound with the chemical inhibitor melatonin (MLT) due to its corresponding good foam stability. When the mass ratio of CaCl2 to MLT was 4:1, the lowest CO release concentration of 7337.06 ppm at 200 °C was observed in the composite inhibitor-treated coal. Furthermore, the addition of 20 wt % of the composite inhibitor resulted in a foam half-life of 3067 min, which was 5.89 times longer than that of the water-based foam. In comparison with the water-based foam, the inhibitory foam based on 20 wt % CaCl2-MLT composite inhibitor exhibited more excellent foam stability, wetting ability, and inhibition performance. The release of CO at 200 °C was 7854.6 ppm, showing a reduction of 63.2% compared to the raw coal. Moreover, the composite inhibitory foam could significantly delay the onset of the characteristic temperature and reduce the weight change during the decomposition stage by 12.8%.

2.
Heliyon ; 10(6): e28155, 2024 Mar 30.
Artículo en Inglés | MEDLINE | ID: mdl-38545184

RESUMEN

Background: In general, the identification of cholesterol-depleted lipid particles can be inferred from non-high-density lipoprotein cholesterol (non-HDL-C) concentration to apolipoprotein B (apoB) concentration ratio, which serves as a reliable indicator for assessing the risk of cardiovascular disease. However, the ability of non-HDL-C/apoB ratio to predict the risk of long-term mortality among the general population remains uncertain. The aim of this study is to explore the association of non-HDL-C/apoB ratio with long-term all-cause and cardiovascular mortality in adults of the United States. Methods: This retrospective cohort study was a further analysis of existing information from the National Health and Nutrition Examination Survey (NHANES). In the ultimate analysis, 12,697 participants from 2005 to 2014 were included. Kaplan-Meier (K-M) curves and the log-rank test were applied to visualize survival differences between groups. Multivariate Cox regression and restricted cubic spline (RCS) models were applied to evaluate the association of non-HDL-C/apoB ratio with all-cause and cardiovascular mortality. Subgroup analysis was conducted for the variables of age, sex, presence of coronary artery disease, diabetes and hypertriglyceridemia and usage of lipid-lowering drugs. Results: The average age of the cohort was 46.8 ± 18.6 years, with 6215 (48.9%) participants being male. During a median follow-up lasting 68.0 months, 891 (7.0%) deaths were documented and 156 (1.2%) patients died of cardiovascular disease. Individuals who experienced all-cause and cardiovascular deaths had a lower non-HDL-C/apoB ratio compared with those without events (1.45 ± 0.16 vs. 1.50 ± 0.17 and 1.43 ± 0.17 vs. 1.50 ± 0.17, both P values < 0.001). The results of adjusted Cox regression models revealed that non-HDL-C/apoB ratio exhibited independent significance as a risk factor for both long-term all-cause mortality [hazard ratio (HR) = 0.51, 95% confidence interval (CI): 0.33-0.80] and cardiovascular mortality (HR = 0.33, 95% CI: 0.12-0.90). Additionally, a significant sex interaction was discovered (P for interaction <0.05), indicating a robust association between non-HDL-C/apoB ratio and long-term mortality among females. The RCS curve showed that non-HDL-C/apoB ratio had a negative linear association with long-term all-cause and cardiovascular mortality (P for non-linearity was 0.098 and 0.314). Conclusions: The non-HDL-C/apoB ratio may serve as a potential biomarker for predicting long-term mortality among the general population, independent of traditional risk factors.

3.
Mol Med Rep ; 25(4)2022 04.
Artículo en Inglés | MEDLINE | ID: mdl-35119079

RESUMEN

Exenatide could reduce blood glucose and alleviate cognitive dysfunction induced by diabetes mellitus (DM). In the present study, a diabetic model was established in Sprague­Dawley rats to further explore the mechanism of exenatide on diabetes­induced cognitive impairment. Notably, the model rats performed poorly in the Morris water maze test and had more apoptotic neurons compared with the control rats. By contrast, exenatide attenuated cognitive impairment and inhibited neuronal apoptosis in the DM rat model. To explore the neuroprotective mechanisms of exenatide, western blotting was performed to detect the expression levels of markers of endoplasmic reticulum stress, including cytochrome c (Cyt­c), Caspase­3, JNK and c­JUN, in hippocampal tissue. Reverse transcription­quantitative PCR was also performed to measure the mRNA expression levels of Cyt­c and Caspase­3. After 16 weeks of treatment, exenatide treatment downregulated Cyt­c, Caspase­3, phosphorylated (p)­JNK and p­c­JUN expression in the hippocampal tissue of diabetic rats. Moreover, Cyt­c, Caspase­3, JNK and JUN expression levels were detected following treatment with a specific inhibitor of JNK (SP600125). The results revealed that SP600125 had similar inhibitory effects on the JNK pathway and ERS­related protein expression (Cyt­t, Caspase­3, p­JNK and p­c­JUN). These results suggested that exenatide improved cognitive dysfunction in DM rats and that the underlying mechanism may be associated with inhibiting apoptosis by suppressing the activation of JNK/c­JUN.


Asunto(s)
Apoptosis/efectos de los fármacos , Disfunción Cognitiva/prevención & control , Diabetes Mellitus Experimental/tratamiento farmacológico , Exenatida/farmacología , Genes jun/efectos de los fármacos , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Fármacos Neuroprotectores/farmacología , Animales , Glucemia/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Caspasa 3/genética , Caspasa 3/metabolismo , Disfunción Cognitiva/etiología , Citocromos c/genética , Citocromos c/metabolismo , Diabetes Mellitus Experimental/complicaciones , Exenatida/uso terapéutico , Hipocampo/efectos de los fármacos , Hipocampo/patología , Insulina/metabolismo , Aprendizaje/efectos de los fármacos , Masculino , Memoria/efectos de los fármacos , Neuronas/citología , Neuronas/efectos de los fármacos , Fármacos Neuroprotectores/uso terapéutico , Ratas Sprague-Dawley
4.
Microb Pathog ; 155: 104880, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-33905870

RESUMEN

The present study was aimed to evaluate the isoxanthanol against Staphylococcus aureus chronic obstructive pulmonary disease (COPD) in rat model. The isoxanthanol decreased the parasitic load by almost 99% in the Staphylococcus aureus infected rats. It significantly (P < 0.05) decreased mortality rate of the rats, prevented pulmonary tissue damage and aggregation of inflammatory cytokines. In Staphylococcus aureus infected rats, isoxanthanol treatment inhibited production of interleukin-18, interleukin-1ß and TNF-α significantly (P < 0.05) in the BALF and pulmonary tissues. Treatment of the Staphylococcus aureus-infected rats with isoxanthanol inhibited up-regulation of NLRP3, ASC and caspase-1 expression. In Staphylococcus aureus-infected rats the expression of miR-145-5p was remarkably increased on treatment with isoxanthanol. In summary, isoxanthanol prevents Staphylococcus aureus-induced COPD in rats through up-regulation of miR-145-5p and suppression of inflammatory cytokines. Therefore, isoxanthanol can be of therapeutic importance for the treatment of Staphylococcus aureus induced COPD.


Asunto(s)
MicroARNs , Enfermedad Pulmonar Obstructiva Crónica , Animales , Pulmón , MicroARNs/genética , Enfermedad Pulmonar Obstructiva Crónica/tratamiento farmacológico , Ratas , Staphylococcus aureus , Factor de Necrosis Tumoral alfa
5.
Gynecol Endocrinol ; 37(7): 591-599, 2021 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-33501880

RESUMEN

BACKGROUND: We aimed to summarize the available data regarding the levels of leptin and adiponectin and the key modulators of endometriosis compared to the controls. METHODS: The electronic databases such as MEDLINE, Embase, Scopus, Cochrane Library, and Web of Science were searched up to October 2020. The circulating and peritoneal levels of leptin and circulating levels of adiponectin were included. We used the Cochrane's Q test and the I2 statistic in this study. These tests' weighted mean difference (WMD) and 95% CIs were considered as the summary effect size. They were then pooled using a random-effects model with the DerSimonian-Laird method. RESULTS: Twenty eligible articles (or 25 studies) with 2645 participants (1362 women with endometriosis and 1283 controls) were included. Pooled results showed that women with endometriosis had significantly higher leptin levels (WMD = 4.45 mg/ml, 95%CI = 2.42-6.49, p < .01) and leptin/BMI ratio (WMD = 0.32 mg/ml, 95%CI = 0.23-0.42, p < .001) than the controls, whereas adiponectin levels (WMD = -0.24 mg/ml, 95%CI = -4.27 to -0.01, p = .038) were significantly lower. The pooled results also indicated significantly lower leptin levels in women with advanced-stage endometriosis (WMD = -8.07 mg/ml, 95%CI = -14.22 to -1.92, p = .01) than in the early stage. It was found, however, that there were no significant differences in adiponectin levels of women with advanced-stage endometriosis (WMD = -0.16 mg/ml, 95%CI = -0.64 to 0.32, p = .512) and the early-stage ones. CONCLUSION: We showed that leptin levels and leptin/BMI ratio were significantly higher in women with endometriosis than the controls. Nonetheless, patients with endometriosis had significantly lower levels of adiponectin than the controls.


Asunto(s)
Adiponectina/metabolismo , Endometriosis/metabolismo , Leptina/metabolismo , Índice de Masa Corporal , Femenino , Humanos
6.
Ying Yong Sheng Tai Xue Bao ; 31(6): 1783-1790, 2020 Jun.
Artículo en Chino | MEDLINE | ID: mdl-34494728

RESUMEN

The flux and form of dissolved inorganic carbon (DIC), an important part of carbon budget, play a key role in the biogeochemistry of aquatic ecosystem. By analyzing physicochemical parameters and water DIC and δ13CDIC characteristics in Wanfenghu Reservoir, we examined the behavior and source of DIC. In the epilimnion, water pH in the entire reservoir was conservative, being weakly alkaline. Nitrate (NO3--N) had the maximum coefficient of variation and a high spatio-temporal variation. Due to the dilution effect, the lowest values of electrical conductivity (EC), partial pressure of carbon dioxide (pCO2) and DIC appeared during the summer high flow phase. On the water column in summer, redox potential (Eh) and NO3--N did not change with water depth, while other indicators changed significantly, with greatest variation in the thermocline. Water temperature (T), pH and Eh all decreased with increasing water depth in both seasons, while pCO2 showed an opposite trend. Water EC, total alkalinity (TA), and DIC decreased with increa-sing water depth in summer, but with a smaller gradient of change in winter. The DIC in water was negatively correlated with water pH and Eh, while positively correlated with EC and pCO2 in both seasons. 2) The concentration of DIC was 2.66-4.9 mmol·L-1 in summer and 3.38-4.52 mmol·L-1 in winter. During the period of thermal stratification, the variation gradients of DIC and δ13CDIC in the thermocline were most significant. DIC was positively correlated with δ13CDIC of epilimnion in summer. DIC was negatively correlated with δ13CDIC in epilimnion in winter and on water column in both summer and winter. However, the variation of DIC and δ13CDIC with water depth was not obvious in winter. 3) In summer, δ13CDIC was -7.71‰- -1.38‰, indicating that the dissolution of carbonate minerals was dominant. In winter, δ13CDIC was -16.93‰- -9.44‰, signifi-cantly lower than that in summer but with a wider range, indicating biological input of CO2 and mineralization of organic matter were the main sources. The δ13CDIC varied significantly in different seasons and water depths because of differences in carbon sources and changes in the relative contribution proportion of carbon sources.


Asunto(s)
Ecosistema , Monitoreo del Ambiente , Isótopos de Carbono/análisis , China , Estaciones del Año
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA